We are live on ! Find out more
Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Portfolio holdings

AUM $33B
1-Year Est. Return 40.62%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+40.62%
3 Year Est. Return
+99.15%
5 Year Est. Return
+129.95%
10 Year Est. Return
+402.57%
AUM
$29.7B
AUM Growth
+$2.13B
Cap. Flow
+$780M
Cap. Flow %
2.63%
Top 10 Hldgs %
24.23%
Holding
394
New
76
Increased
92
Reduced
78
Closed
81

Top Buys

Rank Stock Value
1
ENTG icon
Entegris
ENTG
+$302M
2
COF icon
Capital One
COF
+$248M
3
SLM icon
SLM Corp
SLM
+$166M
4
LEN icon
Lennar Class A
LEN
+$138M
5
CVX icon
Chevron
CVX
+$126M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$277M
2
J icon
Jacobs Solutions
J
+$157M
3
CRH icon
CRH
CRH
+$145M
4
MTB icon
M&T Bank
MTB
+$119M
5
LVS icon
Las Vegas Sands
LVS
+$92.7M

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Financials 16%
3 Industrials 10.12%
4 Consumer Discretionary 9.65%
5 Healthcare 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
276
Integra LifeSciences
IART
$1.32B
$3.37K ﹤0.01%
275
CALY
277
Callaway Golf Company
CALY
$2.8B
$3.37K ﹤0.01%
419
+335
+399% +$2.3K
CWH icon
278
Camping World
CWH
$675M
$3.23K ﹤0.01%
188
HOUS
279
DELISTED
Anywhere Real Estate
HOUS
$3.23K ﹤0.01%
891
BCC icon
280
Boise Cascade
BCC
$2.78B
$3.21K ﹤0.01%
+37
New +$3.35K
RUSHA icon
281
Rush Enterprises Class A
RUSHA
$8.36B
$3.19K ﹤0.01%
+62
New +$3.15K
SHOO icon
282
Steven Madden
SHOO
$3.31B
$3.09K ﹤0.01%
+129
New +$3.03K
ACLS icon
283
Axcelis
ACLS
$3.73B
$3.07K ﹤0.01%
+44
New +$2.51K
NAVI icon
284
Navient
NAVI
$879M
$3K ﹤0.01%
213
FUL icon
285
H.B. Fuller
FUL
$3.11B
$2.71K ﹤0.01%
45
-206
-82% -$11.4K
EVH icon
286
Evolent Health
EVH
$562M
$2.66K ﹤0.01%
236
+180
+321% +$1.65K
SCS
287
DELISTED
Steelcase
SCS
$2.53K ﹤0.01%
+243
New +$2.5K
OMCL icon
288
Omnicell
OMCL
$1.53B
$2.53K ﹤0.01%
+86
New +$2.57K
HY icon
289
Hyster-Yale Materials Handling
HY
$617M
$2.47K ﹤0.01%
+62
New +$2.47K
VREX icon
290
Varex Imaging
VREX
$779M
$2.34K ﹤0.01%
270
FOLD
291
DELISTED
Amicus Therapeutics
FOLD
$2.2K ﹤0.01%
384
+218
+131% +$1.41K
BOOM icon
292
DMC Global
BOOM
$137M
$2.19K ﹤0.01%
272
ZD icon
293
Ziff Davis
ZD
$1.91B
$2.09K ﹤0.01%
+69
New +$2.22K
MDXG icon
294
MiMedx Group
MDXG
$643M
$2.05K ﹤0.01%
+336
New +$2.23K
SRDX
295
DELISTED
Surmodics
SRDX
$2.05K ﹤0.01%
+69
New +$1.99K
DIN icon
296
Dine Brands
DIN
$444M
$2.04K ﹤0.01%
84
FORR icon
297
Forrester Research
FORR
$224M
$1.89K ﹤0.01%
+191
New +$1.9K
JBLU icon
298
JetBlue
JBLU
$1.9B
$1.83K ﹤0.01%
+432
New +$1.93K
GOGL
299
DELISTED
Golden Ocean Group
GOGL
$1.65K ﹤0.01%
226
NEO icon
300
NeoGenomics
NEO
$2.23B
$1.63K ﹤0.01%
+223
New +$1.8K

Similar funds

Barrow, Hanley, Mewhinney & Strauss's Q2 2025 Portfolio in Review

As of Q2 2025, Barrow, Hanley, Mewhinney & Strauss held 394 positions worth $29.7B, up 7.7% from $27.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barrow, Hanley, Mewhinney & Strauss's Q2 2025 filing shows 76 new, 92 increased, 78 reduced and 81 closed positions. Its largest new stake was Capital One: 1,331,368 shares worth $283M. The largest sale was Elevance Health, an estimated $277M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

  • Barrow, Hanley, Mewhinney & Strauss's largest Q2 2025 buy was Capital One: 1,331,368 shares worth $283M.
  • Barrow, Hanley, Mewhinney & Strauss added most to Entegris in Q2 2025, an estimated $302M increase.
  • Barrow, Hanley, Mewhinney & Strauss's biggest Q2 2025 reduction was Elevance Health, cutting an estimated $277M.
  • Barrow, Hanley, Mewhinney & Strauss fully exited Discover Financial Services in Q2 2025, selling an estimated $68.4M.
  • Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 24% of its $29.7B portfolio in Q2 2025.
  • Barrow, Hanley, Mewhinney & Strauss opened 76 new positions and closed 81 in Q2 2025.
  • Barrow, Hanley, Mewhinney & Strauss's portfolio value rose 7.7% quarter-over-quarter to $29.7B.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.